Prescribing patterns of anti-asthma drugs in pediatric patients

Acta Paediatrica Taiwanica

Volumn 46, Issue 4, 2005, Pages

  Sun, Hai Lun ^a,b   Lue, Ko Huang ^a,b   Kao, Yea Huei ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Asthma; Pediatrics; Prescribing pattern

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR STIMULATING AGENT; XANTHINE;

ARTICLE; ASTHMA; BRONCHITIS; BRONCHOPNEUMONIA; CLINICAL TRIAL; COUGHING; HUMAN; LOWER RESPIRATORY TRACT INFECTION; PRACTICE GUIDELINE; PRESCRIPTION; RESPIRATORY TRACT DISEASE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INSURANCE CLAIM REPORTING; LEUKOTRIENE ANTAGONISTS; MALE; PRESCRIPTIONS, DRUG; TAIWAN; XANTHINES;

EID: 29244485889     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59:469-78.
2. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999; 25:402:631-8.
3. Lazarus SC. Inflammation, inflammatory mediators, and mediator antagonists in asthma. J Clin Pharmacol 1998; 38:577-82.
4. National Heart, Lung, and Blood Institute/World Health Organization. Global Initiative for Asthma. Bethesda: National Heart, Lung, and Blood Institute. National Institutes of Health, 1995 (revised 1998).
5. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Bethesda: National Asthma Education and Prevention Program. National Heart, Lung and Blood Institute. National Institutes of Health, 1999.
6. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-32.
7. Walker AM, Szneke P, Weatherby LB, et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 1999; 107: 356-62.
8. Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med 1997; 127:719-24.
9. Smalley W, Shatin D, Wysowski DK, et al. Contraindicated use of cisapride: Impact of Food and Drug Administration regulatory action. JAMA 2000; 284:3036-9.
10. Glauber H, Brown J. Impact of cardiovascular disease on health care utilization in a defined diabetic population. J Clin Epidemiol 1994; 47:1133-43.
11. Chan KA, Truman A, Gurwitz JH, et al. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med 2003; 163:728-34.
12. Bureau of National Health Insurance. National health insurance annual statistical report. Taipei: Bureau of National Health Insurance, 2001.
13. Su TP, Chen TJ, Hwang SJ, Chou LF, Fan AP, Chen YC. Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000. Zhonghua Yi Xue Za Zhi (Taipei) 2002; 65:378-91.
14. Chen TJ, Chou LF, Hwang SJ. Trends in prescribing proton pump inhibitors in Taiwan: 1997-2000. Int J Clin Pharmacol Ther 2003; 41:207-12.
15. Chen TJ, Lin SJ, Chen LK, Hwang SJ, Chou LF. Prevalence of antilipemic drug use in Taiwan: analysis of a sampling cohort within the national health insurance. J Chin Med Assoc 2003; 66:39-45.
16. Chen CY, Chiu HF, Yeh MK, Chang CC, Yang CY. The use of anti-asthmatic medications among pediatric patients in Taiwan. Pharmacoepidemiol Drug Saf 2003; 12:129-33.
17. Thompson R, Dixon F, Watt J, Crane J, Beasley R, Burgess C. Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. N Z Med J 1993; 106:81-3.
18. Buchner DA, Carlson AM, Stempel DA. Patterns of antiinflammatory therapy in the post-guidelines era: a retrospective claims analysis of managed care members. Am J Manag Care 1997; 3:87-93.
19. Eggleston PA, Malveaux FJ, Butz AM, et al. Medications used by children with asthma living in the inner city. Pediatrics 1998; 101:349-54.
20. Lozano P, Sullivan SD, Smith DH, et al. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999; 104:957-63.
21. Goodman DC, Lozano P, Stukel TA, et al. Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics 1999; 140:187-94.
22. Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics 2000; 105:272-6.
23. Beimfohr C, Maziak W, von Mutius E, et al. The use of anti-asthmatic drugs in children: results of a community-based survey in Germany. Pharmacoepidemiol Drug Saf 2001; 10:315-21.
24. Warner JO. Review of prescribed treatment for children with asthma in 1990. Br Med J 1995; 311:663-6.
25. Chen SH, Yin TJ, Huang JL. An exploration of the skills needed for inhalation therapy in schoolchildren with asthma in Taiwan. Ann Allergy Asthma Immunol 2002; 89:311-5.